Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals

Gastroenterology. 2017 Sep;153(3):626-631. doi: 10.1053/j.gastro.2017.07.025. Epub 2017 Jul 27.

Authors

Poonam Mishra¹, Jeffry Florian¹, Joy Peter², Monika Vainorius³, Michael W Fried³, David R Nelson², Debra Birnkrant¹

Affiliations

¹ US Food and Drug Administration, Silver Spring, Maryland.
² University of Florida, Gainesville, Florida.
³ University of North Carolina, Chapel Hill, North Carolina.

PMID: 28757271
DOI: 10.1053/j.gastro.2017.07.025

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adverse Drug Reaction Reporting Systems
Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use*
Cooperative Behavior
Drug Approval*
Drug Therapy, Combination
Hepatitis C, Chronic / diagnosis
Hepatitis C, Chronic / drug therapy*
Humans
Interdisciplinary Communication
Public-Private Sector Partnerships*
Treatment Outcome
United States
United States Food and Drug Administration*

Substances

Antiviral Agents